Chengdu Second Peoples Hospital

The trials here

What the 6 trials at this site are about, from their registry records.

Conditions

• Atopic dermatitis (eczema)4 trials
• Chronic spontaneous urticaria1 trial
• Psoriasis1 trial

Phase

• Phase 34 trials
• Phase 12 trials

Status

• Completed6 trials

Lead sponsor

• Amgen4 trials
• BeiGene1 trial
• BeOne Medicines1 trial

Closed trials

• Recruiting

  A Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of Multiple-Ascending Doses of Tacabrutideg (BGB-16673) in Adults With Chronic Spontaneous Urticaria and in Healthy Participants

  NCT07005713· Phase 1· BeOne Medicines· Source

  Contact: Study Director

• Completed

  A Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of Single- and Multiple-Ascending Doses and Food Effect of BGB-45035 in Healthy Participants and in Adults With Autoimmune Dermatological Diseases

  NCT06342713· Phase 1· BeiGene· Source

• Completed

  A Study to Investigate Efficacy and Safety of Apremilast 30 mg Twice Daily (BID) in Chinese Participants With Moderate to Severe Plaque-type Psoriasis (PsO)

  NCT06122649· Phase 3· Amgen· Source

• Completed

  A Study to Evaluate Rocatinlimab (AMG 451) in Adolescent Participants With Moderate-to-severe Atopic Dermatitis (AD)

  NCT05704738· Phase 3· Amgen· Source

• Completed

  A Study Assessing Rocatinlimab in Combination With Topical Corticosteroid and/or Topical Calcineurin Inhibitors in Adult Participants With Moderate-to-severe Atopic Dermatitis (AD)

  NCT05724199· Phase 3· Amgen· Source

• Completed

  A Study Evaluating Rocatinlimab in Moderate-to-severe Atopic Dermatitis (ROCKET-IGNITE)

  NCT05398445· Phase 3· Amgen· Source